• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    More On SAZ.DE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Stada-Arzneimittel AG (SAZ.DE)

    -XETRA
    27.09 Down 0.37(1.33%) Jan 23, 11:35AM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 480,000   495,000   507,000   578,000  
    Cost of Revenue257,000  265,000  258,000  289,000  
    Gross Profit 223,000   230,000   249,000   289,000  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative -   -   -   -  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses416,000  437,000  444,000  510,000  
    Operating Income or Loss 64,000   58,000   63,000   68,000  
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -   -   -  
    Earnings Before Interest And Taxes64,000  58,000  63,000  68,000  
    Interest Expense(18,000)(18,000)(17,000)(18,000)
    Income Before Tax -   -   -   -  
    Income Tax Expense13,000  7,000  15,000  16,000  
    Minority Interest(2,000)(1,000)(1,000) -  
    Net Income From Continuing Ops34,000  33,000  36,000  31,000  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 32,000   32,000   35,000   31,000  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares -   -   -   -  

    Currency in EUR.